Acquisition of Six Sites

The MedicX Fund Limited
05 December 2006


For immediate release                                            5 December 2006



                              MedicX Fund Limited

                  ('MedicX Fund', 'the Fund' or 'the Company')



                        Acquisition of Six Further Sites



MedicX Fund, the specialist investor in modern purpose built primary healthcare
properties which on 2 November 2006 listed on the Official List of the London
Stock Exchange, today announces that it has completed the acquisition of
Medcentres Property Limited for £4.52 million, a portfolio of six completed
sites, from the NJ and D Arnold Settlement trust.  The purchase price paid was
£3.52 million in cash and £1 million in MedicX Fund shares issued at a price of
£1 per share.  Immediately following acquisition Medcentres repaid bank debt of
£7.56 million.  This acquisition was not included in the pipeline reported in
the Medicx Fund prospectus.



Medcentres owns six completed properties in Colchester, Marlborough, Norfolk,
Dorset, Northleach and Swindon.  The current rent of the properties is £737,000
per annum in aggregate and the properties have been valued by DTZ Debenham Tie
Leung, valuers to the MedicX Fund, at £13.1m.  The six new sites bring the total
number of primary healthcare properties owned by the MedicX Fund to 22 in total.
  Medcentres Property Ltd will be renamed MedicX Properties III Ltd.



Keith Maddin, Chairman of MedicX Group, said: 'We are very pleased to have
completed this acquisition which was not included within our pipeline at the
time of the MedicX Fund's prospectus.  These properties further expand MedicX
Fund's presence in the south of England.'



                                      End



For further information please contact:

MedicX Group                                                [phone]

Keith Maddin, Chairman
Mike Adams, Managing Director


Buchanan Communications                                    [phone]

Charles Ryland / Lisa Baderoon / Mary-Jane Johnson




                      This information is provided by RNS
            The company news service from the London Stock Exchange